SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 10-Q


                  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934




For Quarter Ended                 May 1, 1999
Commission File Number              0-3319


                          DEL GLOBAL TECHNOLOGIES CORP.
                          -----------------------------
             (Exact name of registrant as specified in its charter)


           New York                                           13-1784308
           --------                                           ----------
(State or other jurisdiction of                            (I.R.S. Employer
 incorporation or organization)                            Identification No.)

                      One Commerce Park, Valhalla, NY 10595
                      -------------------------------------
                    (Address of principal executive offices)
                                   (Zip Code)

                                 (914) 686-3600
                                 --------------
               (Registrant's telephone number including area code)


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports)  and  (2)  has  been  subject  to such  filing
requirements for the past 90 days.

Yes   X                No

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the close of the business on June 9, 1999.



                            Common Stock - 7,772,884




<PAGE>





                                     PART I


Item 1.  Financial Statements

              Consolidated Balance Sheets - May 1,1999 and August 1, 1998

              Consolidated Statements of Income for the Three Months and Nine
              Months Ended May 1, 1999 and May 2, 1998

              Consolidated Statements of Cash Flows for the Nine Months Ended
              May 1, 1999 and May 2, 1998

              Notes to Consolidated Financial Statements


                                       -1-

<PAGE>



                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEETS
                                   (Unaudited)

                                     ASSETS
                                                         May 1,       August  1,
                                                         1999           1998
                                                     -----------     -----------

CURRENT ASSETS
        Cash and cash equivalents                    $   952,144     $ 3,401,697
        Investments available-for-sale                 1,068,384         913,125
        Trade receivables - net                       15,927,676      14,341,744
        Cost and estimated earnings in
             excess of billings on
             uncompleted contracts                     5,441,540       3,306,673
        Inventory                                     34,936,021      29,195,262
        Prepaid expenses and other
             current assets                            2,306,413       1,358,847
                                                     -----------     -----------
             Total current assets                     60,632,178      52,517,348
                                                     -----------     -----------

FIXED ASSETS - Net                                    13,864,911      12,739,509
INTANGIBLES - Net                                        812,782         941,443
GOODWILL - Net                                         5,648,726       4,809,255
DEFERRED CHARGES                                         294,889         387,044
OTHER ASSETS                                             984,183         962,028
                                                     -----------     -----------
        TOTAL                                        $82,237,669     $72,356,627
                                                     ===========     ===========

                      LIABILITIES AND SHAREHOLDERS' EQUITY


CURRENT LIABILITIES
         Current portion of long-term debt           $   550,309     $   120,410
         Accounts payable - trade                      7,016,236       5,403,403
         Accrued liabilities                           4,496,002       3,938,623
         Deferred compensation liability               1,173,749         913,046
         Income taxes                                  1,436,813         394,540
                                                     -----------     -----------
              Total current liabilities               14,673,109      10,770,022
                                                     -----------     -----------

LONG-TERM LIABILITIES
         LONG-TERM DEBT (less current
              portion included above)                  1,263,773         240,273
         OTHER                                           591,206         484,366
         DEFERRED INCOME TAXES                         1,598,709       1,406,162
                                                     -----------     -----------
              Total liabilities                       18,126,797      12,900,823
                                                     -----------     -----------

SHAREHOLDERS' EQUITY
         Common stock, $.10 par value;
              Authorized 20,000,000 shares;
              Issued and outstanding -
              8,157,979 shares at May 1, 1999
              and 7,988,993 shares at
              August 1, 1998                             815,799         798,898
         Additional paid-in capital                   50,085,345      49,124,456
         Retained earnings                            17,168,435      12,360,906
                                                     -----------     -----------
                                                      68,069,579      62,284,260
         Less common stock in treasury -
              445,237 shares at May 1, 1999
              and 299,746 at August 1, 1998            3,958,707       2,828,456
                                                     -----------     -----------
              Total shareholders' equity              64,110,872      59,455,804
                                                     -----------     -----------
         TOTAL                                       $82,237,669     $72,356,627
                                                     ===========     ===========

   See notes to consolidated financial statements


                                       -2-

<PAGE>



                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES

                        CONSOLIDATED STATEMENTS OF INCOME

                                   (Unaudited)

<TABLE>
<CAPTION>
                                         Three Months Ended              Nine Months Ended
                                     ---------------------------    ---------------------------
                                         May 1,         May 2,          May 1,         May 2,
                                         1999           1998            1999           1998
                                     ------------   ------------    ------------   ------------
<S>                                  <C>            <C>             <C>            <C>
NET SALES                            $ 18,684,525   $ 16,682,726    $ 49,416,143   $ 44,565,977
                                     ------------   ------------    ------------   ------------
COSTS AND EXPENSES:
     Cost of sales                     11,216,870      9,995,579      29,204,291     26,546,139
     Research and development           1,753,406      1,548,915       4,707,649      4,249,161
     Selling, general and
         administrative                 3,064,658      3,019,143       8,435,479      7,897,980
     Interest expense (income)
         - net                             78,577         (5,530)        101,289       (104,080)
                                     ------------   ------------    ------------   ------------
                                       16,113,511     14,558,107      42,448,708     38,589,200
                                     ------------   ------------    ------------   ------------
INCOME BEFORE PROVISION
     FOR INCOME TAXES                   2,571,014      2,124,619       6,967,435      5,976,777
PROVISION FOR INCOME TAXES                797,015        679,878       2,159,905      1,912,569
                                     ------------   ------------    ------------   ------------
NET INCOME                           $  1,773,999   $  1,444,741    $  4,807,530   $  4,064,208
                                     ============   ============    ============   ============

NET INCOME PER COMMON
     SHARE AND COMMON SHARE
     EQUIVALENTS:
     BASIC                           $        .23   $        .19    $        .63   $        .54
                                     ============   ============    ============   ============
     DILUTED                         $        .22   $        .18    $        .59   $        .50
                                     ============   ============    ============   ============

Weighted average number of
     common shares outstanding          7,700,294      7,541,988       7,658,666      7,484,513
                                     ============   ============    ============   ============
Weighted average number of
     common shares outstanding and
     common share equivalents           8,163,269      8,228,828       8,163,470      8,191,038
                                     ============   ============    ============   ============
</TABLE>



See notes to consolidated financial statements


                                       -3-

<PAGE>



                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES

                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (Unaudited)

                                                          Nine Months Ended
                                                     --------------------------
                                                        May 1,         May 2,
                                                        1999           1998
                                                     -----------    -----------
CASH FLOWS FROM OPERATING ACTIVITIES:
   Net Income                                        $ 4,807,530    $ 4,064,208
     Adjustments to reconcile net income
       to net cash provided by operating
       activities net of effects of acquisitions:
       Depreciation                                    1,287,436      1,026,803
       Amortization                                      508,615        405,290
       Deferred income tax provision                     192,547        115,602
       Tax benefit from exercise of stock options
          and warrants                                   450,530        780,959
       Imputed interest                                   62,986         62,751
       Amortization of stock-based compensation           16,822        101,123
       Changes in assets and liabilities:
         Increase in trade receivables                (1,585,932)    (1,836,497)
         Increase in cost and estimated earnings
            in excess of billings on uncompleted
            contracts                                 (2,134,867)    (1,018,231)
         Increase in inventory                        (5,290,759)    (2,530,225)
         Increase in prepaid and other current assets (1,014,802)      (530,755)
         (Increase) decrease in other assets             (22,875)         1,285
         Increase in accounts payable - trade          1,612,833      1,577,410
         Increase in accrued liabilities                 584,712        789,818
         Increase in deferred compensation liability     260,703        136,510
         Increase (decrease) in income taxes payable   1,042,273       (163,904)
                                                     -----------    -----------
   Net cash provided by operating activities             777,752      2,982,147
                                                     -----------    -----------

CASH FLOWS FROM INVESTING ACTIVITIES:
       Net cash paid on acquisition of subsidiaries     (550,018)      (899,926)
       Expenditures for fixed assets                  (2,412,838)    (1,731,275)
       Investment in marketable securities              (114,459)      (160,537)
       Payments to former shareholders of
               subsidiaries acquired                    (119,569)       (56,772)
                                                     -----------    -----------
   Net cash used in investing activities              (3,196,884)    (2,848,510)
                                                     -----------    -----------

CASH FLOWS FROM FINANCING ACTIVITIES:
       Net proceeds from (repayment of) bank
          borrowing                                      653,399       (147,272)
       Payment for repurchase of shares               (1,130,251)    (1,430,852)
       Proceeds from exercise of stock options
          and warrants                                   448,498      1,275,801
       Other                                              (2,067)        40,497
                                                     -----------    -----------
   Net cash used in financing activities                 (30,421)      (261,826)
                                                     -----------    -----------

                                                                     (Continued)
See notes to consolidated financial statements


                                       -4-

<PAGE>







                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES

                      CONSOLIDATED STATEMENTS OF CASH FLOWS

                                   (Unaudited)
                                                          Nine Months Ended
                                                     --------------------------
                                                        May 1,         May 2,
                                                        1999           1998
                                                     -----------    -----------

NET DECREASE IN CASH AND CASH EQUIVALENTS            $(2,449,553)   $  (128,189)
CASH AND CASH EQUIVALENTS, BEGINNING OF
PERIOD                                                 3,401,697      6,070,608
                                                     -----------    -----------
CASH AND CASH EQUIVALENTS, END OF PERIOD             $   952,144    $ 5,942,419
                                                     ===========    ===========

SUPPLEMENTAL DISCLOSURES OF CASH FLOW
   INFORMATION:
      Interest paid                                  $   142,395    $    36,109
                                                     ===========    ===========
      Income taxes paid                              $   473,940    $ 1,091,188
                                                     ===========    ===========

SUPPLEMENTAL SCHEDULE OF INVESTING AND
   FINANCING ACTIVITIES:
      Acquisition of selected assets                 $ 1,508,702    $   994,455
      Acquisition costs in accrued expenses                 --          (94,529)
      Payment due under acquisition term notes          (958,684)          --
                                                     -----------    -----------
      Net cash paid to acquire selected assets       $   550,018    $   899,926
                                                     ===========    ===========


See notes to consolidated financial statements



                                       -5-

<PAGE>



                 DEL GLOBAL TECHNOLOGIES CORP. AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

                                   (Unaudited)


NOTE 1         In  the  opinion of the Company's  management,  the  accompanying
               unaudited   consolidated   financial   statements   contain   all
               adjustments  (consisting  of only normal  recurring  adjustments)
               necessary  to  present   fairly  the  results  of  the  Company's
               financial  position  as of May 1,  1999  and the  results  of its
               operations  and its cash flows for the nine  months  ended May 1,
               1999 and May 2, 1998.

               The accounting  policies followed by the Company are set forth in
               Note 1 to the  Company's  financial  statements  as of  August 1,
               1998.

               The  consolidated   financial   statements   should  be  read  in
               conjunction  with the  notes to the  financial  statements  as of
               August 1, 1998.

               Certain  reclassifications  have been made in the prior  period's
               financial  statements  to  correspond  to  the  current  period's
               presentation.

NOTE 2         The  results  of  operations  for the three  month and nine month
               periods ended May 1, 1999 are not  necessarily  indicative of the
               results to be expected for the full year.

NOTE 3         INVESTMENTS AND DEFERRED COMPENSATION

               At May 1, 1999, the Company had set aside  $1,173,749 of deferred
               compensation  for its  President and certain key  executives.  Of
               this  amount   $153,926  was  in  cash  and   $1,068,384  was  in
               investments    available-for-sale.    Included   in   investments
               available-for-sale are $48,561 of U. S. Treasury bonds and equity
               securities  held  by the  Company  for its  own  account  and are
               recorded  at fair  market.  At August 1, 1998,  the  Company  had
               $913,046 of deferred  compensation for its President which was in
               investments   available-for   sale.  The  deferred   compensation
               liability  at May 1, 1999 and August 1, 1998 was  $1,173,749  and
               $913,046,  respectively. Gains and losses on the investments held
               to fund the deferred compensation, either recognized or realized,
               inure to the  benefit  or  detriment  of the  President's  or key
               executives'  individual  deferred   compensation.   Realized  and
               unrealized gains and losses on investments held for the Company's
               account  in the  nine-month  period  ended  May 1,  1999 were not
               material and are recorded in the financial statements.


NOTE 4         PERCENTAGE OF COMPLETION ACCOUNTING
                                                                     Nine Months
                                                                        Ended
                                              May 1,      August 1,     May 1,
                                              1999          1998        1999
                                           -----------  -----------  -----------
               Costs incurred on
                  uncompleted contracts    $12,151,273  $ 6,804,554  $ 5,346,719

               Estimated earnings            7,611,727    4,178,103    3,433,624
                                           -----------  -----------  -----------
                                            19,763,000   10,982,657    8,780,343

               Less billings to date        14,321,460    7,675,984    6,645,476
                                           -----------  -----------  -----------
               Costs and estimated
                  earnings in excess of
                  billings on uncompleted
                  contracts                $ 5,441,540  $ 3,306,673  $ 2,134,867
                                           ===========  ===========  ===========


               The backlog of unshipped  contracts being accounted for under the
               percentage of completion  method of accounting was  approximately
               $4.2 million at May 1, 1999.






                                       -6-

<PAGE>



NOTE 5         INVENTORY

               Inventory is stated at the lower of cost (first-in, first-out) or
               market.

               Inventories  and their effect on cost of sales are  determined by
               physical count for annual reporting purposes and are estimated by
               management for interim reporting purposes.

               Inventory consists of the following:        May 1,    August 1,
                                                           1999        1998
                                                       -----------  -----------

               Finished goods                          $ 5,801,962  $ 4,848,572
               Work-in-process                          15,963,420   11,333,936
               Raw material and purchased parts         13,170,639   13,012,754
                                                       -----------  -----------
               Total                                   $34,936,021  $29,195,262
                                                       ===========  ===========


NOTE 6         FIXED ASSETS

               Fixed assets consist of the following:
                                                           May 1,    August 1,
                                                           1999        1998
                                                       -----------  -----------
               Land                                    $   694,046  $   694,046
               Building                                  2,146,025    2,146,025
               Machinery and equipment                  13,538,604   11,370,262
               Furniture and fixtures                    1,582,778    1,484,310
               Leasehold improvements                    1,643,192    1,613,883
               EDP equipment                             2,007,991    1,891,272
               Transportation equipment                     30,103       30,103
                                                       -----------  -----------
                                                        21,642,739   19,229,901

               Less accumulated depreciation
                  and amortization                       7,777,828    6,490,392
                                                       -----------  -----------

               Net fixed assets                        $13,864,911  $12,739,509
                                                       ===========  ===========


NOTE 7         NET INCOME PER COMMON SHARE AND COMMON SHARE EQUIVALENTS

               During  the year  ended  August  1,  1998,  the  Company  adopted
               Statement  of  Financial  Accounting  Standard  ("SFAS") No. 128,
               "Earnings  Per Share." This  statement is effective for financial
               statements  issued for periods  ending  after  December 15, 1997.
               Basic and diluted  earnings per share have been  restated for all
               prior periods to reflect the adoption of SFAS No. 128.


NOTE 8         ACQUISITION

               In December 1998, the Company acquired certain selected assets of
               Acoma  Medical  Imaging  Inc. for  approximately  $1.4 million in
               cash,  including expenses,  payable over a three-year period. The
               acquired assets consisted of inventory and technology.


NOTE 9         EFFECT OF NEW ACCOUNTING PRONOUNCEMENTS

               Reporting  Comprehensive  Income.  In June  1997,  the  Financial
               Accounting   Standards   Board  ("FASB")  issued  SFAS  No.  130,
               "Reporting Comprehensive Income." This statement is effective for
               years beginning after December 15, 1997. Management has evaluated
               the effect of this statement on its financial  reporting from the
               adoption  of  this  statement  and  has  found  that  no  further
               disclosures are needed.

               Disclosures   About   Segments  of  an  Enterprise   and  Related
               Information.  In  June  1997,  the  FASB  issued  SFAS  No.  131,
               "Disclosures   About   Segments  of  an  Enterprise  and  Related
               Information."  SFAS No. 131 requires the  reporting of profit and
               loss, specific revenue and expense items and assets for


                                       -7-

<PAGE>



               reportable segments. It also requires the reconciliation of total
               segment  revenues,  total segment profit and loss,  total segment
               assets  and  other  amounts   disclosed  for  segments,   to  the
               corresponding   amounts   in  the   general   purpose   financial
               statements.   This   statement  is  effective  for  fiscal  years
               beginning  after  December  15,  1997.  The  Company  has not yet
               determined  what  additional   disclosures  may  be  required  in
               connection with adopting SFAS No. 131.

               Disclosures about Pensions and Other Postretirement  Benefits. In
               February  1998,   the  FASB  issued  SFAS  No.  132,   "Employers
               Disclosures  about Pensions and Other  Postretirement  Benefits."
               This statement revises employers'  disclosures about pensions and
               other  postretirement  benefit  plans.  It does  not  change  the
               measurement  or  recognition  of those  plans.  SFAS  No.  132 is
               effective  for fiscal years  beginning  after  December 15, 1997.
               Management  does not  anticipate  that this statement will have a
               significant  effect  on  the  Company's   consolidated  financial
               statements.

               Disclosures about Derivative  Instruments and Hedging Activities.
               In June 1998,  the FASB  issued  SFAS No.  133,  "Accounting  for
               Derivative  Instruments  and  Hedging  Activities."  SFAS No. 133
               establishes  accounting  and reporting  standards for  derivative
               instruments and hedging activities. SFAS No. 133 is effective for
               all quarters of all fiscal  years  beginning  after  December 15,
               1999.  Management  does not  anticipate  that this statement will
               have  any  effect  on  the   Company's   consolidated   financial
               statements.



                                       -8-

<PAGE>



Item 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
         AND RESULTS OF OPERATIONS

This  Management  Discussion and Analysis of Financial  Condition and Results of
Operations contains forward-looking  statements. Such statements involve various
risks that may cause actual results to differ  materially.  These risks include,
but are not  limited to, the  ability of the  Company to grow  internally  or by
acquisition  and  to  integrate  acquired   businesses,   changing  industry  or
competitive   conditions,   and  other  risks   referred  to  in  the  Company's
registration  statements  and periodic  reports  filed with the  Securities  and
Exchange Commission.

OVERVIEW

                 The  Company's  net sales  have  increased  as a result of both
internal growth and acquisitions. The Company has completed five acquisitions in
the past five years:  Dynarad (a designer and  manufacturer  of medical  imaging
systems and critical  electronic  subsystems) in fiscal 1993; Bertan (a designer
and  manufacturer  of precision high voltage power supplies and  instrumentation
for  medical  and  industrial   applications)  in  fiscal  1994;  Gendex-Del  (a
manufacturer of medical  imaging  systems) in fiscal 1996,  X-Ray  Technologies,
Inc.  (a  manufacturer  of medical  imaging  systems)  in fiscal  1998 and Acoma
Medical Imaging Inc. (a manufacturer of medical imaging systems) in fiscal 1999.
The  Company's  net sales have  increased  from  approximately  $24.3 million in
fiscal 1994 to approximately  $62.3 million in fiscal 1998, a compounded  annual
growth rate of 26.5%.

                 During the past five years the Company has grown internally and
through  acquisitions into a company whose  predominant  business is serving the
medical imaging and diagnostic markets.  The Company's net sales attributable to
medical imaging products have increased from approximately $9.4 million or 38.7%
of total net sales in fiscal 1994 to approximately $35.6 million or 65% of total
net sales and  approximately  $43.9  million or 71% of total net sales in fiscal
years 1997 and 1998, respectively.

                 Management  believes that recent cost containment trends in the
healthcare  industry have created  opportunities for its cost-effective  medical
imaging systems and subsystems in domestic and  international  markets.  Some of
these trends are increased demand for lower cost medical equipment,  outsourcing
of systems and critical  electronic  subsystems  by leading  original  equipment
manufacturers  ("OEMs"),  increased demand for certain diagnostic procedures and
lower cost medical services in the global marketplace.

RESULTS OF OPERATIONS

                 Net  sales  for  the  three  months  ended  May  1,  1999  were
approximately  $18.7 million as compared to approximately  $16.7 million for the
three  months  ended May 2, 1998,  an increase of 12.0%.  Net sales for the nine
months  ended  May 1, 1999 were  approximately  $49.4  million  as  compared  to
approximately  $44.6  million for the nine months ended May 2, 1998, an increase
of 10.9%. These increases were due to internal growth from existing operations.

                 Cost of sales, as a percentage of net sales,  for the three and
nine months ended May 1, 1999 were 60.0% and 59.1%, respectively, as compared to
59.9% and 59.6%, respectively, for the prior corresponding periods.

                 Research  and  development  expenses  were  approximately  $1.8
million and $1.5 million for the three month  periods  ended May 1, 1999 and May
2,  1998,   respectively.   Research  and  development   expenses  increased  to
approximately  $4.7  million  for  the  nine  months  ended  May  1,  1999  from
approximately $4.2 million for the nine months ended May 2, 1998, an increase of
10.8%.  The increase was primarily due to new product  development.  The Company
continues  to invest in  research  and  development  in order to  introduce  new
state-of-the-art products for its medical and industrial markets.

                 Selling, general and administrative expenses were approximately
$3.1 million,  or 16.4% of net sales, for the three months ended May 1, 1999, as
compared to  approximately  $3.0  million,  or 18.1% of net sales,  for the same
period  in  the  prior  year,   a  decrease  of  1.7%.   Selling,   general  and
administrative  expenses were approximately $8.4 million, or 17.1% of net sales,
for the nine months ended May 1, 1999 as compared to approximately $7.9 million,
or 17.7% of net sales, for the same period in the prior year, a decrease of .6%.

                 Net interest  expense was  approximately  $79,000 for the three
months ended May 1, 1999 as compared to interest income of approximately  $6,000
for the  corresponding  period in the  prior  year.  Net  interest  expense  was
approximately $101,000 for the nine months ended May 1, 1999, as compared to net
interest income of approximately  $104,000 for the  corresponding  period in the
prior year.  Net interest  expense was the result of higher  levels of long-term
debt for the three and nine month periods ended May 1, 1999.


                                       -9-

<PAGE>
                 Income tax expense  was 31% of pretax  income for the three and
nine months ended May 1, 1999 and 32% for the three and nine months ended May 2,
1998.  The decrease  from  statutory  rates is primarily due to sales being made
through the Company's  Foreign Sales  Corporation,  research and development and
other tax credits.

                 Net income  increased  to  approximately  $1.8  million for the
three months ended May 1, 1999, an increase of 22.8%,  from  approximately  $1.4
million for the prior  corresponding  period.  Basic  earnings per share for the
three months ended May 1, 1999  increased to $.23 from $.19 for the three months
ended May 2, 1998, an increase of 21.1%. Diluted earnings per share rose to $.22
from $.18 for the three months ended May 1, 1999 and May 2, 1998,  respectively,
an increase of 22.2%. The weighted  average number of common shares  outstanding
at May 1, 1999 were  7,700,294,  as compared to  7,541,988  at May 2, 1998.  The
weighted average number of common shares and common share  equivalents at May 1,
1999 decreased to 8,163,269 from 8,228,828 at May 2, 1998. Net income  increased
to approximately $4.8 million for the nine months ended May 1, 1999, an increase
of 18.3%, from  approximately $4.1 million for the prior  corresponding  period.
Basic earnings per share for the nine months ended May 1, 1999 increased to $.63
from $.54 for the nine months ended May 2, 1998,  an increase of 16.7%.  Diluted
earnings  per share rose to $.59 from $.50 for the nine months ended May 1, 1999
and May 2, 1998,  respectively,  an increase of 18%. The weighted average number
of common  shares  outstanding  at May 1, 1999 were  7,658,666  as  compared  to
7,484,513  at May 2, 1998.  The  weighted  average  number of common  shares and
common share equivalents at May 1, 1999 decreased to 8,163,470 from 8,191,038 at
May 2, 1998.  The  increase  in net income for the three and nine month  periods
ended May 1, 1999 was due to internal growth and improved gross margins.

                 The   backlog   of   unshipped   orders  at  May  1,  1999  was
approximately $42 million.


LIQUIDITY AND CAPITAL RESOURCES

                 The Company has funded its operations and acquisitions  through
a combination of cash flow from  operations,  bank borrowing and the issuance of
the Company's common stock.

                 Working  Capital.  At May 1,  1999  and  August  1,  1998,  the
Company's  working  capital was  approximately  $46.0 million and $41.7 million,
respectively.  At such dates the Company  had  approximately  $952,000  and $3.4
million, respectively, in cash and cash equivalents.

                 Trade receivables at May 1, 1999 increased  approximately  $1.6
million as compared to August 1, 1998, primarily due to increased sales levels.

                 Cost  and   estimated   earnings   in  excess  of  billings  on
uncompleted  contracts  increased to  approximately  $5.4 million at May 1, 1999
from  approximately  $3.3  million  at August 1, 1998 due to new  contracts  and
additional work performed during the period on long term contracts accounted for
under the percentage of completion method of accounting.

                 Inventory at May 1, 1999 increased  approximately $5.7 million,
as compared to August 1, 1998,  primarily  because of higher  levels of sales of
medical systems and subsystems and the acquisition of Acoma Medical Imaging Inc.
inventory during the period.

                 Prepaid  expenses  and  other  current  assets  at May 1,  1999
increased  approximately  $948,000,  as  compared  to  August  1,  1998,  due to
increases  in prepaid  trade  show  expenses  and  prepaid  expenses  related to
increased acquisition activity.

                 Trade accounts payable increased  approximately $1.6 million at
May 1, 1999 from August 1, 1998  primarily  because of higher levels of sales of
medical systems and subsystems.

                 Credit Facility and Borrowing.  At May 1, 1999, the Company had
a $14.0 million  revolving  credit line and a $10.0 million  acquisition  credit
line. The available portion of the revolving credit line was approximately $13.4
million,  after  deducting  borrowings  of $445,000 and  outstanding  letters of
credit of approximately $125,000.
There was $9.5 million available under the Company's acquisition credit line.

                 Capital  Expenditures.  The  Company  continues  to  invest  in
capital  equipment,  principally for its manufacturing  operations,  in order to
improve its  manufacturing  efficiency  and  capacity.  The Company has expended
approximately $2.4 million for capital equipment for the nine-month period ended
May 1, 1999.


                                      -10-

<PAGE>
                 The Company anticipates that cash generated from operations and
amounts  available  under its bank  lending  facilities  will be  sufficient  to
satisfy its current operating cash needs.

                 Shareholders'   Equity.   Shareholders'   equity  increased  to
approximately  $64.1 million at May 1, 1999 from approximately  $59.5 million at
August 1, 1998.  This was  primarily  due to the results of  operations  and the
exercise of 147,143 stock options and 15,000 warrants with proceeds of $448,498,
reduced by the repurchase of 145,491 shares at a cost of $1,130,251.

                 Year 2000. The Company has initiated a company-wide program and
developed a formal plan to identify, evaluate and implement changes to products,
computer systems,  applications and  infrastructure  necessary to achieve a year
2000 date  conversion  with no effect on  customers  or  disruption  to business
operations.  These actions are necessary to ensure that all systems and business
applications will recognize and process the year 2000 and beyond.

                 The Company uses purchased  software  programs for a variety of
functions,  including drafting and design,  general accounting and manufacturing
applications.  Currently, all of the Company's products, software for design and
drafting  applications  and accounting and  manufacturing  are fully  compliant.
Other peripheral  computer systems and software have been evaluated and steps to
achieve  compliance are being  implemented.  At this time, the Company  believes
that it does not have any  internal  mission  critical  year 2000 issues that it
cannot remedy.

                 As  part  of  the  year  2000  readiness  process,  significant
customers,  service  providers,  vendors and  suppliers  who are  believed to be
critical to business  operations  after January 1, 2000 have been identified and
steps  are  underway  in an  attempt  to  reasonably  ascertain  their  stage of
readiness.   The  Company  is   surveying   them   primarily   through   written
correspondence.  With respect to mission  critical  third  parties,  the Company
intends to create  contingency  plans to  mitigate  its  exposure  to such third
parties  that are not year 2000  compliant.  In the event any  mission  critical
third  parties do not  achieve  full  compliance,  the  Company  believes it has
sufficient  alternative  resources  upon which to rely.  Despite  its efforts to
ascertain the readiness of its customers,  suppliers and service providers,  the
Company  cannot be certain as to the actual year 2000  readiness  of these third
parties or the  impact  their  noncompliance  may have on the  Company's  future
financial position, the results of its operations or its cash flows.

                 With respect to the Company's  internal  year 2000  compliance,
the Company has and expects to incur capital  equipment  expenditures as well as
staff and consulting costs to achieve compliance.  The Company believes that all
costs to be incurred for all year 2000 compliance related projects will not have
a material effect on the Company's  future  financial  position,  results of its
operations or its cash flows.

                 The Company  expects to achieve full  compliance  no later than
September 30, 1999.

EFFECTS OF NEW ACCOUNTING PRONOUNCEMENTS

                 Reporting  Comprehensive  Income. In June 1997, the FASB issued
SFAS No. 130, "Reporting  Comprehensive Income." This statement is effective for
years beginning after December 15, 1997.  Management has evaluated the effect of
this  statement on its financial  reporting  from the adoption of this statement
and has found that no further disclosures are needed.

                 Disclosures   About  Segments  of  an  Enterprise  and  Related
Information.  In June 1997,  the FASB issued SFAS No.  131,  "Disclosures  About
Segments of an Enterprise  and Related  Information."  SFAS No. 131 requires the
reporting of profit and loss,  specific revenue and expense items and assets for
reportable  segments.  It also  requires  the  reconciliation  of total  segment
revenues,  total segment profit and loss, total segment assets and other amounts
disclosed  for segments,  to the  corresponding  amounts in the general  purpose
financial  statements.  This  statement is effective for fiscal years  beginning
after  December 15, 1997.  The Company has not yet  determined  what  additional
disclosures may be required in connection with adopting SFAS No. 131.

                 Disclosures about Pensions and Other  Postretirement  Benefits.
In February 1998,  the FASB issued SFAS No. 132,  "Employers  Disclosures  about
Pensions and Other  Postretirement  Benefits." This statement revises employers'
disclosures about pensions and other  postretirement  benefit plans. It does not
change the measurement or recognition of those plans.  SFAS No. 132 is effective
for  fiscal  years  beginning  after  December  15,  1997.  Management  does not
anticipate  that this statement will have a significant  effect on the Company's
consolidated financial statements.

                                      -11-

<PAGE>
                 Disclosures   about   Derivative    Instruments   and   Hedging
Activities.  In June  1998,  the FASB  issued  SFAS  No.  133,  "Accounting  for
Derivative  Instruments  and  Hedging  Activities."  SFAS  No.  133  establishes
accounting  and  reporting  standards  for  derivative  instruments  and hedging
activities.  SFAS No. 133 is  effective  for all  quarters  of all fiscal  years
beginning  after December 15, 1999.  Management  does not  anticipate  that this
statement  will  have  any  effect  on  the  Company's   consolidated  financial
statements.


Item 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

                 Not applicable.


                                      -12-

<PAGE>



                                     PART II

Item 1.        Legal Proceedings

                        None

Item 2.        Changes in Securities

                        None

Item 3.        Defaults on Senior Securities

                        None

Item 4.        Submission to a Vote of Security Holders

                        None

Item 5.        Other Information

                        None

Item 6.        Exhibits and Reports on Form 8-K

               (a)      Exhibits:   Exhibit 11 - Computation   of  Earnings  per
                                                 Common Share
                                    Exhibit 27 - Financial Data Schedule


               (b)      Report on Form 8-K:   None



                                      -13-

<PAGE>



                                   SIGNATURES


        Pursuant to the requirements of the Securities and Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned, thereunto duly authorized.









                                                DEL GLOBAL TECHNOLOGIES CORP.



                                                /S/LEONARD A. TRUGMAN
                                                ---------------------
                                                Leonard A. Trugman
                                                Chairman of the Board,
                                                Chief Executive Officer
                                                and President




                                                /S/MICHAEL H. TABER
                                                ---------------------
                                                Michael H. Taber
                                                Chief Financial Officer,
                                                Vice President of Finance
                                                and Secretary



Dated: June 10, 1999







                                      -14-